Huanyu Xu1, Liron Abuhatzira1, Gilberto N Carmona1, Suryakiran Vadrevu2, Leslie S Satin2, Abner L Notkins3. 1. Experimental Medicine Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA. 2. Brehm Diabetes Research Center, University of Michigan Medical School, Ann Arbor, MI, USA. 3. Experimental Medicine Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA. anotkins@dir.nidcr.nih.gov.
Abstract
AIMS/HYPOTHESIS: miR-153 is an intronic miRNA embedded in the genes that encode IA-2 (also known as PTPRN) and IA-2β (also known as PTPRN2). Islet antigen (IA)-2 and IA-2β are major autoantigens in type 1 diabetes and are important transmembrane proteins in dense core and synaptic vesicles. miR-153 and its host genes are co-regulated in pancreas and brain. The present experiments were initiated to decipher the regulatory network between miR-153 and its host gene Ia-2β (also known as Ptprn2). METHODS: Insulin secretion was determined by ELISA. Identification of miRNA targets was assessed using luciferase assays and by quantitative real-time PCR and western blots in vitro and in vivo. Target protector was also employed to evaluate miRNA target function. RESULTS: Functional studies revealed that miR-153 mimic suppresses both glucose- and potassium-induced insulin secretion (GSIS and PSIS, respectively), whereas miR-153 inhibitor enhances both GSIS and PSIS. A similar effect on dopamine secretion also was observed. Using miRNA target prediction software, we found that miR-153 is predicted to target the 3'UTR region of the calcium channel gene, Cacna1c. Further studies confirmed that Cacna1c mRNA and protein are downregulated by miR-153 mimics and upregulated by miR-153 inhibitors in insulin-secreting freshly isolated mouse islets, in the insulin-secreting mouse cell line MIN6 and in the dopamine-secreting cell line PC12. CONCLUSIONS/ INTERPRETATION: miR-153 is a negative regulator of both insulin and dopamine secretion through its effect on Cacna1c expression, which suggests that IA-2β and miR-153 have opposite functional effects on the secretory pathway.
AIMS/HYPOTHESIS: miR-153 is an intronic miRNA embedded in the genes that encode IA-2 (also known as PTPRN) and IA-2β (also known as PTPRN2). Islet antigen (IA)-2 and IA-2β are major autoantigens in type 1 diabetes and are important transmembrane proteins in dense core and synaptic vesicles. miR-153 and its host genes are co-regulated in pancreas and brain. The present experiments were initiated to decipher the regulatory network between miR-153 and its host gene Ia-2β (also known as Ptprn2). METHODS:Insulin secretion was determined by ELISA. Identification of miRNA targets was assessed using luciferase assays and by quantitative real-time PCR and western blots in vitro and in vivo. Target protector was also employed to evaluate miRNA target function. RESULTS: Functional studies revealed that miR-153 mimic suppresses both glucose- and potassium-induced insulin secretion (GSIS and PSIS, respectively), whereas miR-153 inhibitor enhances both GSIS and PSIS. A similar effect on dopamine secretion also was observed. Using miRNA target prediction software, we found that miR-153 is predicted to target the 3'UTR region of the calcium channel gene, Cacna1c. Further studies confirmed that Cacna1c mRNA and protein are downregulated by miR-153 mimics and upregulated by miR-153 inhibitors in insulin-secreting freshly isolated mouse islets, in the insulin-secreting mouse cell line MIN6 and in the dopamine-secreting cell line PC12. CONCLUSIONS/ INTERPRETATION:miR-153 is a negative regulator of both insulin and dopamine secretion through its effect on Cacna1c expression, which suggests that IA-2β and miR-153 have opposite functional effects on the secretory pathway.
Authors: Maricruz Anaya-Ruiz; Jorge Cebada; Guadalupe Delgado-López; María Luisa Sánchez-Vázquez; José Luis Martín Pérez-Santos Journal: Asian Pac J Cancer Prev Date: 2013
Authors: C Seisenberger; V Specht; A Welling; J Platzer; A Pfeifer; S Kühbandner; J Striessnig; N Klugbauer; R Feil; F Hofmann Journal: J Biol Chem Date: 2000-12-15 Impact factor: 5.157
Authors: Atsutaka Kubosaki; Shinichiro Nakamura; Anne Clark; John F Morris; Abner L Notkins Journal: Endocrinology Date: 2005-11-03 Impact factor: 4.736
Authors: Leslie A Caromile; Anush Oganesian; Scott A Coats; Ronald A Seifert; Daniel F Bowen-Pope Journal: J Biol Chem Date: 2010-01-22 Impact factor: 5.157
Authors: Soo Mi Kim; Franziska Theilig; Yan Qin; Tao Cai; Diane Mizel; Robert Faulhaber-Walter; Hiroki Hirai; Sebastian Bachmann; Josephine P Briggs; Abner L Notkins; Jurgen Schnermann Journal: Am J Physiol Renal Physiol Date: 2008-11-19
Authors: Rebecca S Mathew; Antonis Tatarakis; Andrii Rudenko; Erin M Johnson-Venkatesh; Yawei J Yang; Elisabeth A Murphy; Travis P Todd; Scott T Schepers; Nertila Siuti; Anthony J Martorell; William A Falls; Sayamwong E Hammack; Christopher A Walsh; Li-Huei Tsai; Hisashi Umemori; Mark E Bouton; Danesh Moazed Journal: Elife Date: 2016-12-21 Impact factor: 8.140